| [1] | Jesus P, Martins AM, Chiacchio ND, et al. Genital angiokeratoma in a woman with Fabry disease: the dermatologist′s role[J]. An Bras Dermatol, 2018,93(3):426⁃428. doi: 10.1590/abd1806⁃4841. 20187128. | 
																													
																							| [2] | Yasuike R, Nakai N, Komori S, et al. Angiokeratoma corporis diffusum in the absence of metabolic disorders: a case report and mini⁃review of the published work[J]. J Dermatol, 2013,40(8):668⁃669. doi: 10.1111/1346⁃8138.12187. | 
																													
																							| [3] | 王华, 刘宇, 王雷, 等. 匐行性血管瘤19例临床及组织病理学分析[J]. 实用皮肤病学杂志, 2015,8(2):99⁃101. doi: 10.11786/ sypfbxzz.1674⁃1293.20150206. | 
																													
																							| [4] | Wang L, Yuan W, Geng S, et al. Expression of lymphatic markers in angiokeratomas[J]. J Cutan Pathol, 2014,41(7):576⁃581. doi: 10.1111/cup.12349. | 
																													
																							| [5] | Trindade F, Torrelo A, Kutzner H, et al. An immunohistochemical study of angiokeratomas of children[J]. Am J Dermatopathol, 2014,36(10):796⁃799. doi: 10.1097/DAD.0000000000000224. | 
																													
																							| [6] | 高天文, 王雷, 廖文俊. 实用皮肤组织病理学[M]. 2版. 北京: 人民卫生出版社, 2017:907⁃923. | 
																													
																							| [7] | Perretta F, Antongiovanni N, Jaurretche S. Major organic involvement in women with Fabry disease in Argentina[J]. ScientificWorld Journal, 2018,2018:6515613. doi: 10.1155/2018/ 6515613. | 
																													
																							| [8] | Guffon N. Clinical presentation in female patients with Fabry disease[J]. J Med Genet, 2003,40(4):e38. doi: 10.1136/jmg.40. 4.e38. | 
																													
																							| [9] | Lu YY, Lu CC, Wu CS, et al. Familial angiokeratoma corporis diffusum without identified enzyme defect[J]. Indian J Dermatol Venereol Leprol, 2015,81(1):46⁃49. doi: 10.4103/0378⁃6323. 148568. | 
																													
																							| [10] | Jha SK, Rauniyar K, Jeltsch M. Key molecules in lymphatic development, function, and identification[J]. Ann Anat, 2018,219:25⁃34. doi: 10.1016/j.aanat.2018.05.003. | 
																													
																							| [11] | Joukov V, Pajusola K, Kaipainen A, et al. A novel vascular endothelial growth factor, VEGF⁃C, is a ligand for the Flt4 (VEGFR⁃3) and KDR (VEGFR⁃2) receptor tyrosine kinases[J]. EMBO J, 1996,15(7):1751. | 
																													
																							| [12] | Bhawan J, Silva C, Taungjaruwinai WM. Inconsistent immunohistochemical expression of lymphatic and blood endothelial cell markers in cutaneous lymphangiomas[J]. J Cutan Pathol, 2013,40(9):801⁃806. doi: 10.1111/cup.12184. |